Patient presents with a history of bladder cancer.  The initial diagnosis of transitional cell carcinoma (TCC), now commonly referred to as urothelial carcinoma, was confirmed on [Date] via cystoscopy and biopsy.  The original tumor stage was [Stage] and grade was [Grade], based on the [Staging System used, e.g., TNM staging].  Treatment at that time included [Treatment details, e.g., transurethral resection of bladder tumor (TURBT), radical cystectomy, chemotherapy regimen specifying drugs and cycles, radiation therapy details].  Subsequent surveillance has included [Surveillance details, e.g., cystoscopies every [Frequency], urine cytology, imaging studies such as CT urogram or MRI].  Current symptoms, if any, include [Symptom details, e.g., hematuria, dysuria, frequency, urgency].  Physical examination reveals [Relevant physical exam findings].  Assessment includes history of bladder cancer, now [Status, e.g., in remission, with recurrence, with metastatic disease].  Plan includes [Plan details, e.g., continued surveillance as per guidelines, repeat cystoscopy, imaging studies, referral to urology or oncology, consideration of immunotherapy or chemotherapy].  Patient education provided regarding bladder cancer recurrence, signs and symptoms to monitor, and importance of follow-up appointments.  Differential diagnoses at initial presentation included urinary tract infection, bladder stones, and other urological malignancies.  ICD-10 code [Appropriate ICD-10 code, e.g., Z85.820] applied.